Shares of Anthem ANTM decreased 0.3% in pre-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share were down 13.76% over the past year to $4.20, which beat the estimate of $4.15.
Revenue of $30,649,000,000 higher by 15.90% from the same period last year, which beat the estimate of $29,750,000,000.
Outlook
Anthem hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
Details Of The Call
Date: Oct 28, 2020
Time: 08:30 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/5qyd3w58
Technicals
Company's 52-week high was at $311.75
52-week low: $171.03
Price action over last quarter: Up 7.27%
Company Profile
Anthem is one of the largest private health insurance organizations nationwide, providing medical benefits to roughly 42 million medical members. The company offers employer, individual, and government-sponsored coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012, Anthem's reach expands beyond those states through government-sponsored programs such as Medicaid, too.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.